28 The cost-effectiveness ratio in the analysis of health care programs

[1]  R. Gelber,et al.  Quality adjusted survival analysis. , 1990, Statistics in medicine.

[2]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  S. Pauker,et al.  The Markov Process in Medical Prognosis , 1983, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  R. Gelber,et al.  Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group. , 1994, Biometrics.

[5]  G. Koch,et al.  Synthesizing evidence from multiple studies. The role of meta-analysis in pharmacoeconomics. , 1996, Medical care.

[6]  J Lipscomb,et al.  Predicting the Cost of Illness , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[7]  A H Briggs,et al.  Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  P. Wakker,et al.  Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.

[9]  J Lipscomb,et al.  Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. , 1993, Journal of clinical epidemiology.

[10]  B. McNeil,et al.  Probabilistic Sensitivity Analysis Using Monte Carlo Simulation , 1985, Medical decision making : an international journal of the Society for Medical Decision Making.

[11]  Robert Fabian,et al.  Valuing health for policy : an economic approach , 1995 .

[12]  C C Blackmore,et al.  Methodologic evaluation of the radiology cost-effectiveness literature. , 1997, Radiology.

[13]  M C Weinstein,et al.  Uncertainty in Decision Models Analyzing Cost-Effectiveness , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[14]  S. Stearns,et al.  Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. , 1996, Statistics in medicine.

[15]  A R Willan,et al.  Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. , 1996, Health economics.

[16]  A. J. Hogan,et al.  Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias. , 1995, Progress in cardiovascular diseases.

[17]  J Mullahy.  What you don't know can't hurt you? Statistical issues and standards for medical technology evaluation. , 1996, Medical care.

[18]  J. Gardiner,et al.  On Parametric Confidence Intervals for the Cost‐Effectiveness Ratio , 2001 .

[19]  Diana B. Petitti,et al.  Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine , 1994 .

[20]  Bernie J. O'Brien,et al.  In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care , 1994, Medical care.

[21]  A A Stinnett,et al.  Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence. , 1999, Health economics.

[22]  A H Briggs,et al.  Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.

[23]  Morris Meisner,et al.  Power and Sample Size in Cost- Effectiveness Analysis , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[24]  A Briggs,et al.  Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.

[25]  A A Stinnett,et al.  Mathematical programming for the efficient allocation of health care resources. , 1996, Journal of health economics.

[26]  E. Pulkstenis,et al.  Estimation of mean quality adjusted survival time. , 1999, Statistics in medicine.

[27]  Kimbroe J. Carter,et al.  Treatment of Early-Stage Breast Cancer in the Elderly , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[29]  J. Kupersmith,et al.  Covariate-adjusted cost–effectiveness ratios , 1999 .

[30]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[31]  J. Hwang,et al.  Estimation of expected quality adjusted survival by cross-sectional survey. , 1996, Statistics in medicine.

[32]  R. Gelber,et al.  Cox regression models for quality adjusted survival analysis. , 1993, Statistics in medicine.

[33]  A Gafni,et al.  Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[34]  M. Tambour,et al.  Bootstrap confidence intervals for cost-effectiveness ratios: some simulation results. , 1998, Health economics.

[35]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[36]  Thomas C. Chalmers,et al.  Economic Analysis in Randomized Control Trials , 1992, Medical care.

[37]  Margaret Holmes-Rovner,et al.  Confidence Intervals for Cost - Effectiveness Ratios , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[38]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[39]  A. Bates,et al.  Prioritization of health care services. A progress report by the Oregon Health Services Commission. , 1991, Archives of internal medicine.

[40]  J. Sacristán,et al.  Use of Confidence Intervals and Sample Size Calculations in Health Economic Studies , 1995, The Annals of pharmacotherapy.

[41]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[42]  A S Detsky,et al.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[43]  David O. Meltzer,et al.  Editorial: Some reflections on cost‐effectiveness analysis , 1998 .

[44]  Anastasios A. Tsiatis,et al.  A consistent estimator for the distribution of quality adjusted survival time , 1997 .

[45]  M. Johannesson,et al.  Outcome measurement in economic evaluation. , 1996, Health economics.

[46]  Anne C. Haddix,et al.  Prevention effectiveness : a guide to decision analysis and economic evaluation , 1996 .

[47]  J R Beck,et al.  Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[48]  Niels Keiding,et al.  Statistical Models Based on Counting Processes , 1993 .

[49]  A A Stinnett.  Adjusting for bias in C/E ratio estimates. , 1996, Health economics.

[50]  G. Bonsel,et al.  Sequence Effects, Health Profiles, and the QALY Model , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[51]  Richard J. Zeckhauser,et al.  Critical ratios and efficient allocation , 1973 .

[52]  J. Kupersmith,et al.  Cost-effectiveness analysis in heart disease, Part I: General principles. , 1994, Progress in cardiovascular diseases.

[53]  C. Blackmore,et al.  ECONOMIC ANALYSES IN OBSTETRICS AND GYNECOLOGY: A METHODOLOGIC EVALUATION OF THE LITERATURE , 1998, Obstetrics and gynecology.

[54]  E. C. Fieller.  SOME PROBLEMS IN INTERVAL ESTIMATION , 1954 .

[55]  M. Johannesson.  The relationship between cost-effectiveness analysis and cost-benefit analysis. , 1995, Social science & medicine.

[56]  B. Efron.  More Efficient Bootstrap Computations , 1990 .

[57]  Jens Præstgaard.  Nonparametric estimation of actuarial values , 1991 .

[58]  Willard G. Manning,et al.  Valuing health care: Statistical issues in cost–effectiveness analyses , 1995 .

[59]  Frank A. Sloan,et al.  Valuing health care : costs, benefits, and effectiveness of pharmaceuticals and other medical technologies , 1995 .

[60]  M Meisner,et al.  Statistical inference for cost-effectiveness ratios. , 1997, Health economics.

[61]  John C. Hershey,et al.  Carrier Screening for Cystic Fibrosis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[62]  C E Phelps,et al.  On the (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses , 1991, International Journal of Technology Assessment in Health Care.

[63]  S. Evers,et al.  Economic evaluation of mental health care interventions. A review. , 1997, Health economics.

[64]  J C Gardiner,et al.  Power and sample assessments for tests of hypotheses on cost-effectiveness ratios. , 2000, Health economics.

[65]  M F Drummond,et al.  Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues , 1991, International Journal of Technology Assessment in Health Care.

[66]  Mark H. Davis.  Markov Models and Optimization , 1995 .

[67]  E Laska,et al.  Statistical methods for cost-effectiveness analyses. , 1996, Controlled clinical trials.

[68]  M Johannesson,et al.  A Note on Confidence Intervals in Cost-Effectiveness Analysis , 1998, International Journal of Technology Assessment in Health Care.

[69]  J. Eisenberg,et al.  Clinical Economics: A Guide to the Economic Analysis of Clinical Practices , 1989 .

[70]  A. J. Hogan,et al.  Cost-effectiveness analysis in heart disease, Part II: Preventive therapies. , 1995, Progress in cardiovascular diseases.

[71]  M Johannesson,et al.  On the decision rules of cost-effectiveness analysis. , 1993, Journal of health economics.